Sevinc Inan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sevinc Inan has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Elgin Turkoz Uluer
Department of Histology and Embryology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
3 shared publications - Kemal Ozbilgin
Department of Histology and Embryology, Faculty of Medicine Manisa Celal Bayar University Manisa Türkiye
3 shared publications - Fatih Çöllü
Division of Biology, Institute of Graduate Studies, Manisa Celal Bayar University
2 shared publications - Gulsah Albayrak
Department of Histology and Embryology, Faculty of Medicine, Celal Bayar University, Manisa 45140, Turkey
2 shared publications Gulsen Giray
2 shared publicationsH Seda Vatansever
2 shared publications
Latest Publications
- 7 August 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (4) , 262
Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: evidence from cell lines and human tissues
- 7 August 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (4) , 262
Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: evidence from cell lines and human tissues
- Open Access
- 22 April 2026
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer
Objective: Lung cancer is characterized by uncontrolled proliferation, loss of apoptosis, angiogenesis, and metastatic potential. Caffeic acid phenethyl ester (CAPE), the major bioactive molecule of propolis, and epigallocatechin gallate (EGCG), a essential polyphenol of green tea, have documented antioxidant, anti-proliferative, and anti-angiogenic effects. This study aimed to investigate the effects of EGCG and CAPE on VEGF and the PI3K/Akt/mTOR signaling pathway, key regulators of lung cancer progression, using in silico and in vitro models. Methods: This study Lung cancer cells (DSMZ/ACC-234) was conducted to demonstrate the inhibition of cell proliferation by the MTT method, molecular binding via autodock vina and protein expression by immunohistochemistry analysis, targeting the VEGF and PI3K/Akt/mTOR pathways with CAPE and EGCG treatment. Results: EGCG and CAPE treatments significantly reduced cell proliferation in lung cancer cells. Untreated cells exhibited strong to very strong immunoreactivity for VEGF and PI3K/Akt/mTOR pathway markers, whereas EGCG reduced these signals to mild–moderate levels and to CAPE moderate–strong levels. Since both treatments resulted in a statistically significant increase in mTORC1 immunoreactivity, molecular docking targeting was performed via it. Conclusion: EGCG and CAPE exhibit significant anti-proliferative and anti-angiogenic effects by adjusting the VEGF and PI3K/Akt/mTOR signaling pathways in lung cancer cells. mTORC1 activation molecular binding affinity is higher in the CAPE-treated group compared to the EGCG group. These findings highlight the therapeutic importance of targeting these pathways in developing novel treatment strategies for lung cancer.
- 22 April 2026
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
Open AccessThe Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer
Objective: Lung cancer is characterized by uncontrolled proliferation, loss of apoptosis, angiogenesis, and metastatic potential. Caffeic acid phenethyl ester (CAPE), the major bioactive molecule of propolis, and epigallocatechin gallate (EGCG), a essential polyphenol of green tea, have documented antioxidant, anti-proliferative, and anti-angiogenic effects. This study aimed to investigate the effects of EGCG and CAPE on VEGF and the PI3K/Akt/mTOR signaling pathway, key regulators of lung cancer progression, using in silico and in vitro models. Methods: This study Lung cancer cells (DSMZ/ACC-234) was conducted to demonstrate the inhibition of cell proliferation by the MTT method, molecular binding via autodock vina and protein expression by immunohistochemistry analysis, targeting the VEGF and PI3K/Akt/mTOR pathways with CAPE and EGCG treatment. Results: EGCG and CAPE treatments significantly reduced cell proliferation in lung cancer cells. Untreated cells exhibited strong to very strong immunoreactivity for VEGF and PI3K/Akt/mTOR pathway markers, whereas EGCG reduced these signals to mild–moderate levels and to CAPE moderate–strong levels. Since both treatments resulted in a statistically significant increase in mTORC1 immunoreactivity, molecular docking targeting was performed via it. Conclusion: EGCG and CAPE exhibit significant anti-proliferative and anti-angiogenic effects by adjusting the VEGF and PI3K/Akt/mTOR signaling pathways in lung cancer cells. mTORC1 activation molecular binding affinity is higher in the CAPE-treated group compared to the EGCG group. These findings highlight the therapeutic importance of targeting these pathways in developing novel treatment strategies for lung cancer.
- 30 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Exécution des arrêts de la cour européenne des droits de l'Homme par la Turquie
Le contentieux turc a donné lieu à plusieurs milliers de constats de violations, lesquels ont engagé la Turquie sur le chemin des réformes par l’adoption des mesures préconisées par la Cour européenne des droits de l’homme et conformément à la nature des violations constatées. Dans ce contexte, la Turquie est tenue d’apporter une réparation individuelle et générale au service de la prévention de la répétition de violations semblables et de la réparation des préjudices subis par les victimes. S’il est vrai que son obligation d’exécution des arrêts est tributaire essentiellement de sa ratification de la CEDH, force est de constater que cet engagement se trouve renforcé par le fait que la Turquie tente d’adhérer à l’Union européenne depuis plusieurs décennies déjà. C’est ainsi que son obligation d’exécution se concrétise par la mise en oeuvre de moyens ayant pour objectif de diminuer les constats de violation prononcés à son encontre. De plus, ces multiples condamnations ne font que ternir l’image de la Turquie sur la scène internationale et leur diminution apparaît comme étant l’occasion de redorer son blason et de réaffirmer son image d’État auprès de la communauté internationale. Néanmoins, sa pratique d’ensemble relative à l’exécution des arrêts de la Cour EDH est loin de lui servir. Au contraire, sa réputation de mauvais élève en matière du respect aux droits de l’homme s’accentue de part son attitude notamment envers certaines libertés fondamentales, comme la liberté d’expression ou la liberté de la presse, et par conséquent, l’exécution des arrêts demeure un sujet préoccupant pour cet État sous certains aspects.
- 30 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Exécution des arrêts de la cour européenne des droits de l'Homme par la Turquie
Le contentieux turc a donné lieu à plusieurs milliers de constats de violations, lesquels ont engagé la Turquie sur le chemin des réformes par l’adoption des mesures préconisées par la Cour européenne des droits de l’homme et conformément à la nature des violations constatées. Dans ce contexte, la Turquie est tenue d’apporter une réparation individuelle et générale au service de la prévention de la répétition de violations semblables et de la réparation des préjudices subis par les victimes. S’il est vrai que son obligation d’exécution des arrêts est tributaire essentiellement de sa ratification de la CEDH, force est de constater que cet engagement se trouve renforcé par le fait que la Turquie tente d’adhérer à l’Union européenne depuis plusieurs décennies déjà. C’est ainsi que son obligation d’exécution se concrétise par la mise en oeuvre de moyens ayant pour objectif de diminuer les constats de violation prononcés à son encontre. De plus, ces multiples condamnations ne font que ternir l’image de la Turquie sur la scène internationale et leur diminution apparaît comme étant l’occasion de redorer son blason et de réaffirmer son image d’État auprès de la communauté internationale. Néanmoins, sa pratique d’ensemble relative à l’exécution des arrêts de la Cour EDH est loin de lui servir. Au contraire, sa réputation de mauvais élève en matière du respect aux droits de l’homme s’accentue de part son attitude notamment envers certaines libertés fondamentales, comme la liberté d’expression ou la liberté de la presse, et par conséquent, l’exécution des arrêts demeure un sujet préoccupant pour cet État sous certains aspects.
- 27 April 2022
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 97 (8) , 593-603
Continuous and intermittent parathyroid hormone administration promotes osteogenic differentiation and activity of programmable cells of monocytic origin
Bone healing deficiencies are challenging for orthopedic practice. The use of stem cells with scaffolds to treat bone tissue losses currently is popular for promoting regeneration of tissue. Programmable cells of monocytic origin (PCMO) may differentiate into three germ layers and may be a promising alternative treatment due to their stem cell-like properties. Parathyroid hormone (PTH) participates in bone metabolism. Intermittent administration of PTH promotes osteogenic activity of mesenchymal stem cdells (MSC). We investigated the osteogenic effects of continuous and intermittent administration of PTH on PCMO. Mononuclear cells were harvested from the peripheral blood of healthy donors. Isolated cells were cultured for six days in a de-differentiation medium. Indirect immunocytochemistry using anti-CD14, anti-CD45 and anti-CD90 primary antibodies, as well as electron microscopy were used to detect PCMO. PCMO then were cultured in an osteogenic differentiation medium supplemented with continuous or intermittent 50 ng/ml PTH. The PTH-free control group (CG), intermittent PTH treated group (IPG) and continuous PTH treated group (CPG) were cultured and assessed for their differentiation into osteogenic lineage cells by indirect immunocytochemistry using anti-collagen I, anti-osteonectin and anti-osteocalcin primary antibodies. Osteoblast-like cells obtained by continuous or intermittent PTH administration exhibited increased levels of collagen I, osteonectin and osteocalcin immunoreactivity. We found that continuous and intermittent PTH administration to PCMO enhanced their differentiation to osteogenic lineage cells and increased osteoblastic activity.
- 27 April 2022
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 97 (8) , 593-603
Continuous and intermittent parathyroid hormone administration promotes osteogenic differentiation and activity of programmable cells of monocytic origin
Bone healing deficiencies are challenging for orthopedic practice. The use of stem cells with scaffolds to treat bone tissue losses currently is popular for promoting regeneration of tissue. Programmable cells of monocytic origin (PCMO) may differentiate into three germ layers and may be a promising alternative treatment due to their stem cell-like properties. Parathyroid hormone (PTH) participates in bone metabolism. Intermittent administration of PTH promotes osteogenic activity of mesenchymal stem cdells (MSC). We investigated the osteogenic effects of continuous and intermittent administration of PTH on PCMO. Mononuclear cells were harvested from the peripheral blood of healthy donors. Isolated cells were cultured for six days in a de-differentiation medium. Indirect immunocytochemistry using anti-CD14, anti-CD45 and anti-CD90 primary antibodies, as well as electron microscopy were used to detect PCMO. PCMO then were cultured in an osteogenic differentiation medium supplemented with continuous or intermittent 50 ng/ml PTH. The PTH-free control group (CG), intermittent PTH treated group (IPG) and continuous PTH treated group (CPG) were cultured and assessed for their differentiation into osteogenic lineage cells by indirect immunocytochemistry using anti-collagen I, anti-osteonectin and anti-osteocalcin primary antibodies. Osteoblast-like cells obtained by continuous or intermittent PTH administration exhibited increased levels of collagen I, osteonectin and osteocalcin immunoreactivity. We found that continuous and intermittent PTH administration to PCMO enhanced their differentiation to osteogenic lineage cells and increased osteoblastic activity.
- Open Access
- 30 December 2021
- Published by Publishing House Zaslavsky in Practical oncology
- Vol. 4 (3-4) , 5-10
Рапаміцин знижує експресію рецепторів гіалуронану в клітинних лініях раку молочної залози MCF-7 та MDA-MB-231
Background. Hyaluronan receptors play a role in various types of cancer. However, the changes occurring in CD44 and RHAMM after rapamycin administration are waiting to be explained. We aimed to investigate the changes in the hyaluronic acid receptors CD44 and RHAMM after rapamycin was administered in MCF-7 and MDA-MB-231 cell lines. Materials and methods. MCF-7 and MDA-MB-231 cell lines were cultured under standard conditions. The cell lines were stained with primary antibodies of CD44 and RHAMM to show the proteins. The H-score values were determined by the intensity of immunoreactivity. QRT-PCR was used to detect the expression of CD44 and RHAMM. Results. In the MCF-7 and MDA-MB-231 cell lines, the immunoreactivity of CD44 and RHAMM decreased at the 24th hour after rapamycin administration compared to the control group. According to the qRT-PCR results, the expression of CD44 (p < 0.033), and RHAMM (p < 0.0002) decreased in the rapamycin group compared to the control group. Conclusions. Rapamycin reduced the effect of hyalorunan receptors on breast cancer cell lines. Thus, the importance of the extracellular matrix in breast cancer has emerged once again.
- 30 December 2021
- Published by Publishing House Zaslavsky in Practical oncology
- Vol. 4 (3-4) , 5-10
Open AccessРапаміцин знижує експресію рецепторів гіалуронану в клітинних лініях раку молочної залози MCF-7 та MDA-MB-231
Background. Hyaluronan receptors play a role in various types of cancer. However, the changes occurring in CD44 and RHAMM after rapamycin administration are waiting to be explained. We aimed to investigate the changes in the hyaluronic acid receptors CD44 and RHAMM after rapamycin was administered in MCF-7 and MDA-MB-231 cell lines. Materials and methods. MCF-7 and MDA-MB-231 cell lines were cultured under standard conditions. The cell lines were stained with primary antibodies of CD44 and RHAMM to show the proteins. The H-score values were determined by the intensity of immunoreactivity. QRT-PCR was used to detect the expression of CD44 and RHAMM. Results. In the MCF-7 and MDA-MB-231 cell lines, the immunoreactivity of CD44 and RHAMM decreased at the 24th hour after rapamycin administration compared to the control group. According to the qRT-PCR results, the expression of CD44 (p < 0.033), and RHAMM (p < 0.0002) decreased in the rapamycin group compared to the control group. Conclusions. Rapamycin reduced the effect of hyalorunan receptors on breast cancer cell lines. Thus, the importance of the extracellular matrix in breast cancer has emerged once again.
- 6 July 2020
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 21 (4) , 242-247
Significant Changes in Trans-Epithelial Barrier Proteins of Adenoid Tissue with Atopic Status in Children
Adenoid tissue,Epithelial barrier,Allergy,Zonula occludens,Claudin,Occludin,Desmoglein,Desmoplakin
- 6 July 2020
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 21 (4) , 242-247
Significant Changes in Trans-Epithelial Barrier Proteins of Adenoid Tissue with Atopic Status in Children
Adenoid tissue,Epithelial barrier,Allergy,Zonula occludens,Claudin,Occludin,Desmoglein,Desmoplakin
- Open Access
- 17 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1020
Anticancer Effects of Oleocanthal and Pinus Pinaster on Breast Cancer Cell in Culture
Phytotherapy has been used for many years due to anticancer and anti-proliferative effects. In this study our purpose was to show the anti-proliferative and apoptotic effects of oleocanthal and pinus pinaster on MCF-7, MDA-MB-231, 67NR and 4T1 breast cancer cell lines. Biological effects of these plants were researched via morphology, MTT assay for cytotoxicity (IC50), immunocytochemical procedure for oxidative stress (eNOS), angiogenesis (VEGF) and TUNEL method for apoptosis. Statistical analysis was performed with the H-score. Oleocanthal and Pinus pinaster extracts showed significant dose and time-dependent inhibition of growth of breast cancer cells. A significant increase in iNOS staining was observed while a decrease in VEGF staining was observed after extract application at IC50 dose. The results showed a significant increase in apoptosis in extract-treated breast cancer cell lines. We showed that the toxic effect of Oleocanthal and Pinus pinaster extracts created by oxidative stress mechanisms. The increase of oxidative stress in breast cancer cells caused the inhibition of cell proliferation and apoptosis. Our results indicated that these plants suggest potential agents in breast cancer treatment. Future studies will focus on the identification of the molecules responsible for anti-cancer activity of these substances in order to improve the quality of life of the patients.
- 17 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1020
Open AccessAnticancer Effects of Oleocanthal and Pinus Pinaster on Breast Cancer Cell in Culture
Phytotherapy has been used for many years due to anticancer and anti-proliferative effects. In this study our purpose was to show the anti-proliferative and apoptotic effects of oleocanthal and pinus pinaster on MCF-7, MDA-MB-231, 67NR and 4T1 breast cancer cell lines. Biological effects of these plants were researched via morphology, MTT assay for cytotoxicity (IC50), immunocytochemical procedure for oxidative stress (eNOS), angiogenesis (VEGF) and TUNEL method for apoptosis. Statistical analysis was performed with the H-score. Oleocanthal and Pinus pinaster extracts showed significant dose and time-dependent inhibition of growth of breast cancer cells. A significant increase in iNOS staining was observed while a decrease in VEGF staining was observed after extract application at IC50 dose. The results showed a significant increase in apoptosis in extract-treated breast cancer cell lines. We showed that the toxic effect of Oleocanthal and Pinus pinaster extracts created by oxidative stress mechanisms. The increase of oxidative stress in breast cancer cells caused the inhibition of cell proliferation and apoptosis. Our results indicated that these plants suggest potential agents in breast cancer treatment. Future studies will focus on the identification of the molecules responsible for anti-cancer activity of these substances in order to improve the quality of life of the patients.
- Open Access
- 10 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1021
Antiproliferative and Apoptotic Effects of the Medicinal Plants on Breast Cancer Cell Lines
Inula viscosa, Rubus caesius and Viscum album known as medicinal plants which have therapeutic properties in treatment of various diseases and particularly cancer. In this study, we aimed to show their anti-proliferative and apoptotic effects on MCF-7, MDA-MB-231, 67NR and 4T1 breast cancer cell lines. The cell lines were cultured to determine the cell growth using the MTT assay. Cells were cultured to evaluate for eNOS, VEGF and apoptosis by immunocytochemical staining and TUNEL assay. Statistical analysis was performed with the H-score. Inula viscosa, Rubus caesius and Viscum album extracts were found to significantly inhibit the growth of breast cancer cell lines in dose and time-dependent manner. eNOS staining was significantly increased and VEGF was decreased after extract application at IC50 dose. Similarly, results indicated that the treated breast cancer cell lines exhibited a marked increase in apoptosis. We showed that the toxic effect of Inula viscosa, Rubus caesius and Viscum album extracts created by oxidative stress and apoptotic mechanisms. Our findings suggested that due to their anticancer potential, these plants may be used as an alternative treatment for the management of cancer. Therefore future studies will focus on the identification of the molecules responsible for the anticancer activity.
- 10 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1021
Open AccessAntiproliferative and Apoptotic Effects of the Medicinal Plants on Breast Cancer Cell Lines
Inula viscosa, Rubus caesius and Viscum album known as medicinal plants which have therapeutic properties in treatment of various diseases and particularly cancer. In this study, we aimed to show their anti-proliferative and apoptotic effects on MCF-7, MDA-MB-231, 67NR and 4T1 breast cancer cell lines. The cell lines were cultured to determine the cell growth using the MTT assay. Cells were cultured to evaluate for eNOS, VEGF and apoptosis by immunocytochemical staining and TUNEL assay. Statistical analysis was performed with the H-score. Inula viscosa, Rubus caesius and Viscum album extracts were found to significantly inhibit the growth of breast cancer cell lines in dose and time-dependent manner. eNOS staining was significantly increased and VEGF was decreased after extract application at IC50 dose. Similarly, results indicated that the treated breast cancer cell lines exhibited a marked increase in apoptosis. We showed that the toxic effect of Inula viscosa, Rubus caesius and Viscum album extracts created by oxidative stress and apoptotic mechanisms. Our findings suggested that due to their anticancer potential, these plants may be used as an alternative treatment for the management of cancer. Therefore future studies will focus on the identification of the molecules responsible for the anticancer activity.
- 26 January 2017
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 131 (3) , 245-252
The effect of local application of insulin-like growth factor for prevention of inner-ear damage caused by electrode trauma
Background: Electrode insertion during cochlear implantation causes cochlear damage and apoptosis. Insulin-like growth factor applied locally was investigated in 21 rats.Methods: In the sham group, an intracochlear dummy electrode was inserted through the round window. In the control group, after the same insertion procedure, saline-soaked porcine skin gelatine was placed on the round window. In the study group, insulin-like growth factor 1 soaked gelatine was placed on the round window. Auditory brainstem response thresholds were measured and histopathological examination was performed.Results: In the study group, at 2–4 kHz, one rat had deterioration, one showed improvement and the rest had stable thresholds 14 days after intervention. At 6 kHz, four rats showed improvement and the rest remained stable. At 8 kHz, four showed improvement, one had deterioration and two remained stable. In the other groups, hearing loss deteriorated in about half of the rats and remained stable in the rest. The mean post-operative 6 kHz threshold was significantly lower than that immediately after the intervention in the study group, contrary to the other groups. The study group had significantly better mean histopathological grading than the other groups.Conclusion: Local insulin-like growth factor 1 application may protect hearing after cochlear implantation.
- 26 January 2017
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 131 (3) , 245-252
The effect of local application of insulin-like growth factor for prevention of inner-ear damage caused by electrode trauma
Background: Electrode insertion during cochlear implantation causes cochlear damage and apoptosis. Insulin-like growth factor applied locally was investigated in 21 rats.Methods: In the sham group, an intracochlear dummy electrode was inserted through the round window. In the control group, after the same insertion procedure, saline-soaked porcine skin gelatine was placed on the round window. In the study group, insulin-like growth factor 1 soaked gelatine was placed on the round window. Auditory brainstem response thresholds were measured and histopathological examination was performed.Results: In the study group, at 2–4 kHz, one rat had deterioration, one showed improvement and the rest had stable thresholds 14 days after intervention. At 6 kHz, four rats showed improvement and the rest remained stable. At 8 kHz, four showed improvement, one had deterioration and two remained stable. In the other groups, hearing loss deteriorated in about half of the rats and remained stable in the rest. The mean post-operative 6 kHz threshold was significantly lower than that immediately after the intervention in the study group, contrary to the other groups. The study group had significantly better mean histopathological grading than the other groups.Conclusion: Local insulin-like growth factor 1 application may protect hearing after cochlear implantation.
- 28 December 2016
- Published by Springer Nature in Biological Trace Element Research
- Vol. 178 (2) , 210-217
A Study on the Anticarcinogenic Effects of Calcium Fructoborate
Evidences about the preventive and therapeutic effects of boron compounds on cancer have been increasing in the last years. Although calcium fructoborate (CaFB) is used as a nutritional supplement, data about its preventive and therapeutic effects on neoplastic transformations are limited. In the present study, the various concentrations of CaFB were applied to the MDA-MB-231 metastatic breast cancer cell line. First, we examined the cytotoxic effect and IC50 value of CaFB by MTT assay. For the evaluation of the DNA damage, apoptosis and metastatic potential, expression levels of ATM, pATM, PARP, p53, p-p53, caspase-3, caspase-9, and VEGF were investigated by using immunoblotting and immunohistochemical methods. Cell viability was significantly reduced at 50 μM CaFB treatment. pATM, p-p53, and caspase-9 levels increased significantly in all groups; furthermore, there was approximately 12.5-, 2.4-, and 10.7-fold increase, respectively, for 100 μM CaFB treatment. ATM and p53 levels did not change with CaFB treatment, but PARP levels significantly 2.5-fold decreased. While VEGF immunoreactivity decreased in all groups, significant increase in caspase-3 immunoreactivity was observed only in the group treated with 50 μM CaFB (p < 0,001). Our results imply that CaFB may have therapeutic potential as well as preventive benefits in cancer.
- 28 December 2016
- Published by Springer Nature in Biological Trace Element Research
- Vol. 178 (2) , 210-217
A Study on the Anticarcinogenic Effects of Calcium Fructoborate
Evidences about the preventive and therapeutic effects of boron compounds on cancer have been increasing in the last years. Although calcium fructoborate (CaFB) is used as a nutritional supplement, data about its preventive and therapeutic effects on neoplastic transformations are limited. In the present study, the various concentrations of CaFB were applied to the MDA-MB-231 metastatic breast cancer cell line. First, we examined the cytotoxic effect and IC50 value of CaFB by MTT assay. For the evaluation of the DNA damage, apoptosis and metastatic potential, expression levels of ATM, pATM, PARP, p53, p-p53, caspase-3, caspase-9, and VEGF were investigated by using immunoblotting and immunohistochemical methods. Cell viability was significantly reduced at 50 μM CaFB treatment. pATM, p-p53, and caspase-9 levels increased significantly in all groups; furthermore, there was approximately 12.5-, 2.4-, and 10.7-fold increase, respectively, for 100 μM CaFB treatment. ATM and p53 levels did not change with CaFB treatment, but PARP levels significantly 2.5-fold decreased. While VEGF immunoreactivity decreased in all groups, significant increase in caspase-3 immunoreactivity was observed only in the group treated with 50 μM CaFB (p < 0,001). Our results imply that CaFB may have therapeutic potential as well as preventive benefits in cancer.